- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Health
Daily Deal Round Up: October 27, 2022
Battery recycler Ascend Elements and Geely spinoff Farizon each raised $300m while Saudi Aramco launched a $1.5bn Sustainability Fund.
Oct 27, 2022Spinouts are thriving despite slump
Spinouts have defied the slump in the rest of the market, with deal numbers up 10% from last year. The average size of seed and series B rounds has actually increased.
Oct 27, 2022The secret to creating a long-lasting CVC unit
Only a small portion of CVCs have lasted longer than two decades. Here are their secrets to staying the course.
Oct 27, 2022How Johnson & Johnson Innovation lasted 5 decades
The oldest standing CVC in the world owes its staying power to discipline, adaptability and unwavering management support says Debi Watson.
Oct 27, 2022Chevron's five keys for CVC longevity
There are five key factors that have helped the US oil and gas company's corporate investment unit keep going for 23 years.
Oct 27, 2022Applied Ventures – rigour and cooperation for longevity
Strong collaboration between Applied Materials and the startups Applied Ventures invests in is part of the reason the CVC unit has kept going so long.
Oct 27, 2022Daily Deal Round Up: October 26, 2022
Wells Fargo, Greystar, Invitation Homes and Prosus were part of Blit Rewards’ $150m round while Mouro Capital co-led Vesttoo’s $80m series C.
Oct 26, 2022Daily Deal Round Up: October 25, 2022
Gradient Ventures participated in a $40m series A round for The Coterie’s while Legal & General led MoneyHub’s $39.5m series B.
Oct 25, 2022Daily Deal Round Up: October 24, 2022
A range of corporates contributed to electric carmaker Aion’s $2.5bn series A round while Prosus took part in a $46m series E for farming services provider DeHaat.
Oct 24, 2022Angelini unveils $293m healthcare venture fund
The European industrial group has formed a unit which will invest in early-stage life sciences and biotech developers through a team headed by Paolo Di Giorgio.
Oct 24, 2022Half of corporate investors negotiate special rights for portfolio company exits
Corporate investors rarely acquire the portfolio companies they invest in, but most will still negotiate special rights around an exit.
Oct 24, 2022Daily Deal Round Up: October 21, 2022
AbbVie is acquiring Amgen-backed DJS Antibodies for $255m while Legend Holdings took part in a $56.6m series C round for VectorBuilder.
Oct 21, 2022Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
